1.
NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The Netherlands
2.
3.
4.
5.
6.
7.
8.
9.
Mining treatment patterns of glucose-lowering medications for type 2 diabetes in the Netherlands